Global AAV Vector-Based Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
AAV vector-based gene therapy drugs are a class of therapeutic agents used in the treatment of genetic disorders and certain diseases These drugs utilize AAV vectors, which are small, non-enveloped viruses that have a low pathogenic profile and are capable of delivering genetic material into host cells. The genetic material, which be a functional gene or a therapeutic gene, is inserted into the AAV vector and then introduced into the patient's cells, where it is intended to correct genetic mutations or produce therapeutic proteins. AAV vector-based gene therapy has shown promising results in clinical trials for conditions such as Leber congenital amaurosis, spinal muscular atrophy, and certain retinal diseases.
According to our (Global Info Research) latest study, the global AAV Vector-Based Gene Therapy Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global AAV Vector-Based Gene Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global AAV Vector-Based Gene Therapy Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global AAV Vector-Based Gene Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global AAV Vector-Based Gene Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global AAV Vector-Based Gene Therapy Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AAV Vector-Based Gene Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AAV Vector-Based Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, Sarepta Therapeutics, Roche, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AAV Vector-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
AAV Vector-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AAV Vector-Based Gene Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AAV Vector-Based Gene Therapy Drugs, with revenue, gross margin, and global market share of AAV Vector-Based Gene Therapy Drugs from 2019 to 2024.
Chapter 3, the AAV Vector-Based Gene Therapy Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and AAV Vector-Based Gene Therapy Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AAV Vector-Based Gene Therapy Drugs.
Chapter 13, to describe AAV Vector-Based Gene Therapy Drugs research findings and conclusion.
According to our (Global Info Research) latest study, the global AAV Vector-Based Gene Therapy Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global AAV Vector-Based Gene Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global AAV Vector-Based Gene Therapy Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global AAV Vector-Based Gene Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global AAV Vector-Based Gene Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global AAV Vector-Based Gene Therapy Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AAV Vector-Based Gene Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AAV Vector-Based Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, Sarepta Therapeutics, Roche, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AAV Vector-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
AAV Vector-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- AAV2 Vector
- AAV5 Vector
- Others
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- uniQure
- Spark Therapeutics
- AveXis (Novartis)
- PTC Therapeutics
- BioMarin
- Sarepta Therapeutics
- Roche
- Pfizer
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AAV Vector-Based Gene Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AAV Vector-Based Gene Therapy Drugs, with revenue, gross margin, and global market share of AAV Vector-Based Gene Therapy Drugs from 2019 to 2024.
Chapter 3, the AAV Vector-Based Gene Therapy Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and AAV Vector-Based Gene Therapy Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AAV Vector-Based Gene Therapy Drugs.
Chapter 13, to describe AAV Vector-Based Gene Therapy Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AAV Vector-Based Gene Therapy Drugs by Type
1.3.1 Overview: Global AAV Vector-Based Gene Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type in 2023
1.3.3 AAV2 Vector
1.3.4 AAV5 Vector
1.3.5 Others
1.4 Global AAV Vector-Based Gene Therapy Drugs Market by Application
1.4.1 Overview: Global AAV Vector-Based Gene Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Diagnostic and Testing Laboratories
1.4.4 Academic and Research Organizations
1.4.5 Others
1.5 Global AAV Vector-Based Gene Therapy Drugs Market Size & Forecast
1.6 Global AAV Vector-Based Gene Therapy Drugs Market Size and Forecast by Region
1.6.1 Global AAV Vector-Based Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global AAV Vector-Based Gene Therapy Drugs Market Size by Region, (2019-2030)
1.6.3 North America AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.6 South America AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 uniQure
2.1.1 uniQure Details
2.1.2 uniQure Major Business
2.1.3 uniQure AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.1.4 uniQure AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 uniQure Recent Developments and Future Plans
2.2 Spark Therapeutics
2.2.1 Spark Therapeutics Details
2.2.2 Spark Therapeutics Major Business
2.2.3 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.2.4 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Spark Therapeutics Recent Developments and Future Plans
2.3 AveXis (Novartis)
2.3.1 AveXis (Novartis) Details
2.3.2 AveXis (Novartis) Major Business
2.3.3 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.3.4 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AveXis (Novartis) Recent Developments and Future Plans
2.4 PTC Therapeutics
2.4.1 PTC Therapeutics Details
2.4.2 PTC Therapeutics Major Business
2.4.3 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.4.4 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 PTC Therapeutics Recent Developments and Future Plans
2.5 BioMarin
2.5.1 BioMarin Details
2.5.2 BioMarin Major Business
2.5.3 BioMarin AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.5.4 BioMarin AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BioMarin Recent Developments and Future Plans
2.6 Sarepta Therapeutics
2.6.1 Sarepta Therapeutics Details
2.6.2 Sarepta Therapeutics Major Business
2.6.3 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.6.4 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sarepta Therapeutics Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.7.4 Roche AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Roche Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.8.4 Pfizer AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AAV Vector-Based Gene Therapy Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of AAV Vector-Based Gene Therapy Drugs by Company Revenue
3.2.2 Top 3 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
3.2.3 Top 6 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
3.3 AAV Vector-Based Gene Therapy Drugs Market: Overall Company Footprint Analysis
3.3.1 AAV Vector-Based Gene Therapy Drugs Market: Region Footprint
3.3.2 AAV Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
3.3.3 AAV Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AAV Vector-Based Gene Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global AAV Vector-Based Gene Therapy Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global AAV Vector-Based Gene Therapy Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
6.2 North America AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2030)
6.3 North America AAV Vector-Based Gene Therapy Drugs Market Size by Country
6.3.1 North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
6.3.2 United States AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
7.2 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
7.3 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country
7.3.1 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.3 France AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Market Size by Region
8.3.1 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2030)
8.3.2 China AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.5 India AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
9.2 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
9.3 South America AAV Vector-Based Gene Therapy Drugs Market Size by Country
9.3.1 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Country
10.3.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 AAV Vector-Based Gene Therapy Drugs Market Drivers
11.2 AAV Vector-Based Gene Therapy Drugs Market Restraints
11.3 AAV Vector-Based Gene Therapy Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AAV Vector-Based Gene Therapy Drugs Industry Chain
12.2 AAV Vector-Based Gene Therapy Drugs Upstream Analysis
12.3 AAV Vector-Based Gene Therapy Drugs Midstream Analysis
12.4 AAV Vector-Based Gene Therapy Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AAV Vector-Based Gene Therapy Drugs by Type
1.3.1 Overview: Global AAV Vector-Based Gene Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type in 2023
1.3.3 AAV2 Vector
1.3.4 AAV5 Vector
1.3.5 Others
1.4 Global AAV Vector-Based Gene Therapy Drugs Market by Application
1.4.1 Overview: Global AAV Vector-Based Gene Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Diagnostic and Testing Laboratories
1.4.4 Academic and Research Organizations
1.4.5 Others
1.5 Global AAV Vector-Based Gene Therapy Drugs Market Size & Forecast
1.6 Global AAV Vector-Based Gene Therapy Drugs Market Size and Forecast by Region
1.6.1 Global AAV Vector-Based Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global AAV Vector-Based Gene Therapy Drugs Market Size by Region, (2019-2030)
1.6.3 North America AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.6 South America AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 uniQure
2.1.1 uniQure Details
2.1.2 uniQure Major Business
2.1.3 uniQure AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.1.4 uniQure AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 uniQure Recent Developments and Future Plans
2.2 Spark Therapeutics
2.2.1 Spark Therapeutics Details
2.2.2 Spark Therapeutics Major Business
2.2.3 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.2.4 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Spark Therapeutics Recent Developments and Future Plans
2.3 AveXis (Novartis)
2.3.1 AveXis (Novartis) Details
2.3.2 AveXis (Novartis) Major Business
2.3.3 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.3.4 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AveXis (Novartis) Recent Developments and Future Plans
2.4 PTC Therapeutics
2.4.1 PTC Therapeutics Details
2.4.2 PTC Therapeutics Major Business
2.4.3 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.4.4 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 PTC Therapeutics Recent Developments and Future Plans
2.5 BioMarin
2.5.1 BioMarin Details
2.5.2 BioMarin Major Business
2.5.3 BioMarin AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.5.4 BioMarin AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BioMarin Recent Developments and Future Plans
2.6 Sarepta Therapeutics
2.6.1 Sarepta Therapeutics Details
2.6.2 Sarepta Therapeutics Major Business
2.6.3 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.6.4 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sarepta Therapeutics Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.7.4 Roche AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Roche Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer AAV Vector-Based Gene Therapy Drugs Product and Solutions
2.8.4 Pfizer AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AAV Vector-Based Gene Therapy Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of AAV Vector-Based Gene Therapy Drugs by Company Revenue
3.2.2 Top 3 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
3.2.3 Top 6 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
3.3 AAV Vector-Based Gene Therapy Drugs Market: Overall Company Footprint Analysis
3.3.1 AAV Vector-Based Gene Therapy Drugs Market: Region Footprint
3.3.2 AAV Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
3.3.3 AAV Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AAV Vector-Based Gene Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global AAV Vector-Based Gene Therapy Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global AAV Vector-Based Gene Therapy Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
6.2 North America AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2030)
6.3 North America AAV Vector-Based Gene Therapy Drugs Market Size by Country
6.3.1 North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
6.3.2 United States AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
7.2 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
7.3 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country
7.3.1 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.3 France AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Market Size by Region
8.3.1 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2030)
8.3.2 China AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.5 India AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
9.2 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
9.3 South America AAV Vector-Based Gene Therapy Drugs Market Size by Country
9.3.1 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Country
10.3.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 AAV Vector-Based Gene Therapy Drugs Market Drivers
11.2 AAV Vector-Based Gene Therapy Drugs Market Restraints
11.3 AAV Vector-Based Gene Therapy Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AAV Vector-Based Gene Therapy Drugs Industry Chain
12.2 AAV Vector-Based Gene Therapy Drugs Upstream Analysis
12.3 AAV Vector-Based Gene Therapy Drugs Midstream Analysis
12.4 AAV Vector-Based Gene Therapy Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. uniQure Company Information, Head Office, and Major Competitors
Table 6. uniQure Major Business
Table 7. uniQure AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 8. uniQure AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. uniQure Recent Developments and Future Plans
Table 10. Spark Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Spark Therapeutics Major Business
Table 12. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 13. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Spark Therapeutics Recent Developments and Future Plans
Table 15. AveXis (Novartis) Company Information, Head Office, and Major Competitors
Table 16. AveXis (Novartis) Major Business
Table 17. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 18. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. PTC Therapeutics Company Information, Head Office, and Major Competitors
Table 20. PTC Therapeutics Major Business
Table 21. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 22. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. PTC Therapeutics Recent Developments and Future Plans
Table 24. BioMarin Company Information, Head Office, and Major Competitors
Table 25. BioMarin Major Business
Table 26. BioMarin AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 27. BioMarin AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. BioMarin Recent Developments and Future Plans
Table 29. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 30. Sarepta Therapeutics Major Business
Table 31. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 32. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Sarepta Therapeutics Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 37. Roche AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Roche Recent Developments and Future Plans
Table 39. Pfizer Company Information, Head Office, and Major Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 42. Pfizer AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Pfizer Recent Developments and Future Plans
Table 44. Global AAV Vector-Based Gene Therapy Drugs Revenue (USD Million) by Players (2019-2024)
Table 45. Global AAV Vector-Based Gene Therapy Drugs Revenue Share by Players (2019-2024)
Table 46. Breakdown of AAV Vector-Based Gene Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in AAV Vector-Based Gene Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 48. Head Office of Key AAV Vector-Based Gene Therapy Drugs Players
Table 49. AAV Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
Table 50. AAV Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
Table 51. AAV Vector-Based Gene Therapy Drugs New Market Entrants and Barriers to Market Entry
Table 52. AAV Vector-Based Gene Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global AAV Vector-Based Gene Therapy Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 54. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
Table 55. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Forecast by Type (2025-2030)
Table 56. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024)
Table 57. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Forecast by Application (2025-2030)
Table 58. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 59. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 60. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 61. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 62. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 63. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 65. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 66. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 69. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 76. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 77. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 78. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 79. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 80. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 81. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 83. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 84. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 85. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 86. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 87. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Global Key Players of AAV Vector-Based Gene Therapy Drugs Upstream (Raw Materials)
Table 89. Global AAV Vector-Based Gene Therapy Drugs Typical Customers
Table 1. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. uniQure Company Information, Head Office, and Major Competitors
Table 6. uniQure Major Business
Table 7. uniQure AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 8. uniQure AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. uniQure Recent Developments and Future Plans
Table 10. Spark Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Spark Therapeutics Major Business
Table 12. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 13. Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Spark Therapeutics Recent Developments and Future Plans
Table 15. AveXis (Novartis) Company Information, Head Office, and Major Competitors
Table 16. AveXis (Novartis) Major Business
Table 17. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 18. AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. PTC Therapeutics Company Information, Head Office, and Major Competitors
Table 20. PTC Therapeutics Major Business
Table 21. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 22. PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. PTC Therapeutics Recent Developments and Future Plans
Table 24. BioMarin Company Information, Head Office, and Major Competitors
Table 25. BioMarin Major Business
Table 26. BioMarin AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 27. BioMarin AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. BioMarin Recent Developments and Future Plans
Table 29. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 30. Sarepta Therapeutics Major Business
Table 31. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 32. Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Sarepta Therapeutics Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 37. Roche AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Roche Recent Developments and Future Plans
Table 39. Pfizer Company Information, Head Office, and Major Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer AAV Vector-Based Gene Therapy Drugs Product and Solutions
Table 42. Pfizer AAV Vector-Based Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Pfizer Recent Developments and Future Plans
Table 44. Global AAV Vector-Based Gene Therapy Drugs Revenue (USD Million) by Players (2019-2024)
Table 45. Global AAV Vector-Based Gene Therapy Drugs Revenue Share by Players (2019-2024)
Table 46. Breakdown of AAV Vector-Based Gene Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in AAV Vector-Based Gene Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 48. Head Office of Key AAV Vector-Based Gene Therapy Drugs Players
Table 49. AAV Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
Table 50. AAV Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
Table 51. AAV Vector-Based Gene Therapy Drugs New Market Entrants and Barriers to Market Entry
Table 52. AAV Vector-Based Gene Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global AAV Vector-Based Gene Therapy Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 54. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
Table 55. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Forecast by Type (2025-2030)
Table 56. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024)
Table 57. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Forecast by Application (2025-2030)
Table 58. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 59. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 60. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 61. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 62. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 63. North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 65. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 66. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 69. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 76. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 77. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 78. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 79. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 80. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 81. South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 83. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 84. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 85. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 86. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 87. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Global Key Players of AAV Vector-Based Gene Therapy Drugs Upstream (Raw Materials)
Table 89. Global AAV Vector-Based Gene Therapy Drugs Typical Customers
LIST OF FIGURES
Figure 1. AAV Vector-Based Gene Therapy Drugs Picture
Figure 2. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type in 2023
Figure 4. AAV2 Vector
Figure 5. AAV5 Vector
Figure 6. Others
Figure 7. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Diagnostic and Testing Laboratories Picture
Figure 11. Academic and Research Organizations Picture
Figure 12. Others Picture
Figure 13. Global AAV Vector-Based Gene Therapy Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global AAV Vector-Based Gene Therapy Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market AAV Vector-Based Gene Therapy Drugs Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 16. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region in 2023
Figure 18. North America AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South America AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global AAV Vector-Based Gene Therapy Drugs Revenue Share by Players in 2023
Figure 25. AAV Vector-Based Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 26. Market Share of AAV Vector-Based Gene Therapy Drugs by Player Revenue in 2023
Figure 27. Top 3 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
Figure 28. Top 6 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
Figure 29. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
Figure 30. Global AAV Vector-Based Gene Therapy Drugs Market Share Forecast by Type (2025-2030)
Figure 31. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Share by Application (2019-2024)
Figure 32. Global AAV Vector-Based Gene Therapy Drugs Market Share Forecast by Application (2025-2030)
Figure 33. North America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. North America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. North America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 36. United States AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. France AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
Figure 50. China AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. India AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. South America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 57. South America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 58. South America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. AAV Vector-Based Gene Therapy Drugs Market Drivers
Figure 68. AAV Vector-Based Gene Therapy Drugs Market Restraints
Figure 69. AAV Vector-Based Gene Therapy Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. AAV Vector-Based Gene Therapy Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. AAV Vector-Based Gene Therapy Drugs Picture
Figure 2. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type in 2023
Figure 4. AAV2 Vector
Figure 5. AAV5 Vector
Figure 6. Others
Figure 7. Global AAV Vector-Based Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Diagnostic and Testing Laboratories Picture
Figure 11. Academic and Research Organizations Picture
Figure 12. Others Picture
Figure 13. Global AAV Vector-Based Gene Therapy Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global AAV Vector-Based Gene Therapy Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market AAV Vector-Based Gene Therapy Drugs Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 16. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region in 2023
Figure 18. North America AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South America AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global AAV Vector-Based Gene Therapy Drugs Revenue Share by Players in 2023
Figure 25. AAV Vector-Based Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 26. Market Share of AAV Vector-Based Gene Therapy Drugs by Player Revenue in 2023
Figure 27. Top 3 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
Figure 28. Top 6 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
Figure 29. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
Figure 30. Global AAV Vector-Based Gene Therapy Drugs Market Share Forecast by Type (2025-2030)
Figure 31. Global AAV Vector-Based Gene Therapy Drugs Consumption Value Share by Application (2019-2024)
Figure 32. Global AAV Vector-Based Gene Therapy Drugs Market Share Forecast by Application (2025-2030)
Figure 33. North America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. North America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. North America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 36. United States AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. France AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
Figure 50. China AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. India AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. South America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 57. South America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 58. South America AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE AAV Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. AAV Vector-Based Gene Therapy Drugs Market Drivers
Figure 68. AAV Vector-Based Gene Therapy Drugs Market Restraints
Figure 69. AAV Vector-Based Gene Therapy Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. AAV Vector-Based Gene Therapy Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
